AlphaStocks
4.3
Weak

Envista Holdings Corp (NVST)

As of Sep 20, 2026, Envista Holdings Corp (NVST) scores 4.3/10 on AlphaStocks' five-model composite, #133 of 168 Health Care stocks. At $23, NVST trades 17% above its model fair value of $20.

Health Care / Health Care Supplies

S&P MidCap 400

$23.36

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#133out of 168 in Health Care

Is Envista Holdings Corp a Good Investment in 2026?

Envista Holdings Corp (NVST) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Envista Holdings Corp as Strong (8/9). The Lynch model is the least favorable, rating it Neutral. Envista Holdings Corp currently trades 17% above its estimated fair value of $20. Envista Holdings Corp ranks #133 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E84.1ROE1.2Market Cap4B

Estimated Fair Value

$20.0517% above

Trading above estimated fair value. P/e of 84x implies high growth expectations.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Attractive

Earnings yield 7.6% · ROC 24%

Frequently Asked Questions

Is Envista Holdings Corp (NVST) a good investment?
As of Sep 20, 2026, Envista Holdings Corp (NVST) scores 4.3/10 on AlphaStocks' five-model composite, #133 of 168 Health Care stocks. At $23, NVST trades 17% above its model fair value of $20. That score is below average, suggesting caution.
What is Envista Holdings Corp's Piotroski F-Score?
Envista Holdings Corp's Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is NVST overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $20, NVST appears overvalued. The stock currently trades 17% above its estimated fair value. Trading above estimated fair value. P/e of 84x implies high growth expectations.
How does NVST compare to other Health Care stocks?
Envista Holdings Corp ranks #133 out of 168 stocks in the Health Care sector, placing it in the top 79% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about NVST?
AlphaStocks evaluates NVST using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.3/10.

Similar Stocks

WSTLNTHMMSI

Compare NVST with

NVST vs WSTLNTH vs NVSTMMSI vs NVSTNVST vs PARRNVST vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer